Lifetech CeraFlex™ Post-Market Surveillance Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT02621528

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02621528
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Germany, Ireland, Italy, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02621528. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (actual); primary completion 2019-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lifetech CeraFlex™ Post-Market Surveillance Study
Condition
Patent Foramen Ovale
Condition
Atrial Septal Defect
Condition
Patent Ductus Arteriosus
Intervention (Device)
CeraFlex
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. (class: industry)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct02621528
Content hash
ad8611730ad16c6fc945f49a13912fadfdbfc9b6230cbdd08a1f5ce494028a8a